India Antimicrobial Resistance Research
India has joined the Global Antimicrobial Resistance Research and Development (R&D) Hub as a new member.
This was announced by the Department of Biotechnology (DBT), Ministry of Science & Technology. This expands the global partnership working to address challenges and improve coordination and collaboration in global AMR R&D to 16 countries.
Ms.Bersabel Ephrem congratulated India on its induction as a new member of the Global Antimicrobial Resistance Research and Development Hub. She is the acting Chair of the Global AMR R&D Hub Board of Members and DG of the Centre for Communicable Diseases and Infection Control at the Public Health Agency of Canada.
She said that she was delighted to welcome India as an essential addition to this global partnership. According to her, addressing AMR requires global action with active participation from all world regions and One Health sectors.
India Antimicrobial Resistance Research- What is The AMR R&D Hub
The Global AMR R&D Hub was launched in May 2018 following a call from G20 Leaders in 2017. The Global AMR R&D Hub supports global priority setting and allocation of resources for AMR R&D. This is through the identification of gaps, overlaps, and cross-sectoral collaboration. The operation
of the Global AMR R&D Hub is supported through a Secretariat, established in Berlin. It is financed through grants from the German Federal Ministry of Education and Research (BMBF) and the Federal Ministry of Health (BMG).From this year onward, India will be Board of members of Global AMR R&D Hub. India looks forward to working with all partners to maximize their existing capabilities, resources, and collectively focus on new R&D intervention to address the increasing drug-resistant. Today, the emergence and spread of AMR continues to be untreated around the world. Given the critical and interdependent human, animal, and environmental dimensions of antimicrobial resistance. The Indian government considers it essential to explore issues of antimicrobial resistance through the lens of One Health approach. Long-term commitments from all stakeholders are required to combat AMR successfully.
